CO5640087A2 - Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos - Google Patents

Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos

Info

Publication number
CO5640087A2
CO5640087A2 CO05058244A CO05058244A CO5640087A2 CO 5640087 A2 CO5640087 A2 CO 5640087A2 CO 05058244 A CO05058244 A CO 05058244A CO 05058244 A CO05058244 A CO 05058244A CO 5640087 A2 CO5640087 A2 CO 5640087A2
Authority
CO
Colombia
Prior art keywords
inflammatory
decongestionantes
pharmacos
histaminic
compositions
Prior art date
Application number
CO05058244A
Other languages
English (en)
Spanish (es)
Inventor
Roger Glen Berlin
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32682029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5640087(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CO5640087A2 publication Critical patent/CO5640087A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CO05058244A 2002-12-18 2005-06-15 Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos CO5640087A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43434202P 2002-12-18 2002-12-18

Publications (1)

Publication Number Publication Date
CO5640087A2 true CO5640087A2 (es) 2006-05-31

Family

ID=32682029

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05058244A CO5640087A2 (es) 2002-12-18 2005-06-15 Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos

Country Status (18)

Country Link
US (1) US7863287B2 (enExample)
EP (1) EP1572206B1 (enExample)
JP (1) JP2006515299A (enExample)
CN (2) CN102406642B (enExample)
AR (1) AR042543A1 (enExample)
AU (1) AU2003301188B2 (enExample)
CA (1) CA2508611C (enExample)
CL (1) CL2003002653A1 (enExample)
CO (1) CO5640087A2 (enExample)
ES (1) ES2468217T3 (enExample)
MX (1) MXPA05006331A (enExample)
NZ (1) NZ540289A (enExample)
PE (2) PE20081072A1 (enExample)
PT (1) PT1572206E (enExample)
RU (1) RU2322262C2 (enExample)
TW (1) TWI313598B (enExample)
WO (1) WO2004056320A2 (enExample)
ZA (1) ZA200504908B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1970055B1 (en) 2005-12-29 2010-11-24 Osmotica Kereskedelmi És Szolgáltató Kft Multi-layered tablet with triple release combination
WO2008114280A1 (en) * 2007-03-21 2008-09-25 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
WO2010056216A1 (en) * 2008-11-11 2010-05-20 Berko Ilac Ve Kimya San.A.S. Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
US8246988B2 (en) 2009-01-05 2012-08-21 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US8377475B2 (en) 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
DK2853262T3 (en) * 2009-10-26 2017-03-06 Sephoris Pharmaceuticals Llc Treatment of sunburn using analgesics and antihistamines
JP5777906B2 (ja) * 2010-02-26 2015-09-09 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
BR112012028153A2 (pt) * 2010-05-03 2018-08-07 Tsh Biopharm Corporation Ltd composição farmacêutica e método para o tratamento de hipertensão
PL2595597T3 (pl) * 2010-07-19 2018-04-30 Procaps S.A. Urządzenie i sposób kapsułkowania kapsułek lub innych stałych postaci leku w kapsułkach
JP5898964B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩を含有する医薬組成物
JP5898963B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
US9216181B2 (en) * 2011-06-08 2015-12-22 Southwest Research Institute BMP-2 upregulating compounds for healing bone tissue and screening methods for selecting such compounds
US10596261B2 (en) * 2013-03-12 2020-03-24 Hercules Incorporated Coprocessed silica coated polymer composition
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
CN107635549A (zh) * 2015-03-26 2018-01-26 杰奎琳·M·艾弗森 抑制与宿醉相关的症状的方法和组合物
CN104758935B (zh) * 2015-04-10 2017-11-21 海口世康药物研究有限公司 一种改善复方布洛芬制剂稳定性的组合物及其制备方法
BR112019005224A2 (pt) 2016-09-26 2019-06-11 The Procter & Gamble Company forma de dosagem para alívio prolongado

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4755532A (en) * 1984-02-08 1988-07-05 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4985459A (en) * 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4683243A (en) * 1984-02-08 1987-07-28 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4906625A (en) * 1984-02-08 1990-03-06 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4840962A (en) * 1984-04-09 1989-06-20 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU738274B2 (en) 1984-04-09 2001-09-13 Procter & Gamble Company, The Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4971785A (en) * 1988-03-14 1990-11-20 Spectrum Consumer Products Co., Inc. Non-alcoholic delivery system for orally ingestible active ingredients
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
KR930701994A (ko) 1990-09-11 1993-09-08 제이코브스 코넬리스 레이서 개선된 진통 효과를 제공하는 방법
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
CA2107331A1 (en) 1991-04-01 1992-10-02 Robert T. Sims Ibuprofen-decongestant combinations
DK0584108T3 (da) * 1991-05-13 2000-10-09 Boots Co Plc Farmaceutisk præparat omfattende ibuprofensalt
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
CA2084028A1 (en) 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US6303632B1 (en) * 1992-09-03 2001-10-16 Sepracor Inc. Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
AU672279B2 (en) 1992-12-21 1996-09-26 Procter & Gamble Company, The Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
EP0674527A1 (en) * 1992-12-21 1995-10-04 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
DE69431153T2 (de) * 1993-06-04 2003-03-13 Warner-Lambert Co., Morris Plains Zubereitungen enthaltend siliciumdioxid zur verbesserung ihres geschmacks
US5466865A (en) * 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
EP0717624A1 (en) 1993-09-07 1996-06-26 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
WO1995007103A1 (en) 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
JPH09509138A (ja) 1993-10-25 1997-09-16 メレルファーマスーティカルズ インコーポレイテッド ターフェナジン及びイブプロフェンの安定な製剤組成物
US5560913A (en) * 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5622723A (en) * 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
AU6599196A (en) 1995-07-28 1997-02-26 Procter & Gamble Company, The Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US5766622A (en) 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
CN1278728A (zh) 1997-09-19 2001-01-03 普罗克特和甘保尔公司 治疗呼吸系统疾病的组合物和方法
US6337091B1 (en) * 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
EP1032392A4 (en) * 1997-10-29 2001-05-09 J Med Pharmaceuticals Inc RHINITIS TREATMENT BY ANTIHISTAMINE / DECONGESTIVUM ADMINISTRATION
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2003024427A1 (en) * 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
JP2002316927A (ja) 2001-04-19 2002-10-31 Taisho Pharmaceut Co Ltd 感冒用組成物
US20040147606A1 (en) 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
AU2003219348A1 (en) 2002-04-22 2003-11-03 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
WO2004048895A1 (ja) 2002-11-22 2004-06-10 Kumamoto Technology & Industry Foundation 移動体ナビゲート情報表示方法および移動体ナビゲート情報表示装置
WO2005063219A2 (en) 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules

Also Published As

Publication number Publication date
CN102406642A (zh) 2012-04-11
RU2005122403A (ru) 2006-01-20
HK1078494A1 (en) 2006-03-17
EP1572206A2 (en) 2005-09-14
AR042543A1 (es) 2005-06-22
US20040186184A1 (en) 2004-09-23
NZ540289A (en) 2006-10-27
AU2003301188A1 (en) 2004-07-14
ZA200504908B (en) 2006-12-27
ES2468217T3 (es) 2014-06-16
HK1166602A1 (en) 2012-11-02
CN102406642B (zh) 2013-04-03
TWI313598B (en) 2009-08-21
RU2322262C2 (ru) 2008-04-20
CA2508611A1 (en) 2004-07-08
CN1726035A (zh) 2006-01-25
PT1572206E (pt) 2014-06-12
WO2004056320A2 (en) 2004-07-08
CL2003002653A1 (es) 2005-04-22
PE20040973A1 (es) 2004-12-14
EP1572206A4 (en) 2007-07-18
JP2006515299A (ja) 2006-05-25
CA2508611C (en) 2011-07-26
EP1572206B1 (en) 2014-04-23
US7863287B2 (en) 2011-01-04
WO2004056320A3 (en) 2004-09-23
TW200413004A (en) 2004-08-01
MXPA05006331A (es) 2005-08-26
PE20081072A1 (es) 2008-08-15
AU2003301188B2 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
AR020015A1 (es) Composiciones de celecoxib
AR042543A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides
ECSP066807A (es) Formulaciones galénicas de compuestos orgánicos
DE60231298D1 (de) Capsaicin-enthaltende missbrauchsichere pharmazeutische zusammensetzungen
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
ATE431738T1 (de) Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
ECSP055569A (es) Forma de dosificación de pramipexol en una dosis única diaria
MX2007007885A (es) Composiciones farmaceuticas oralmente desintegrables con agentes de indicacion sensorial.
PL1643977T3 (pl) Wielocząstkowa postać leku, zawierającego mukoadhezyjnie sformułowane peptydowe lub proteinowe substancje czynne oraz sposób wytwarzania tej postaci leku
ATE442158T1 (de) Oral verabreichte pharmazeutische zusammensetzungen mit einem abgabemittel in mikronisierter form
ECSP003807A (es) Composiciones valdecoxib
UY28517A1 (es) Nueva combinación
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
EP1781277A4 (en) COMBINATION PREPARATION
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
CO5650230A2 (es) Composiciones estables de atorvastatina preparadas con granulacion en humedo
PE20030830A1 (es) Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea
ATE410152T1 (de) Therapeutisches system mit amoxicillin und clavulansäure
DE602005021475D1 (de) Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
AR043370A1 (es) Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga
DE60301261D1 (de) Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist
ECSP11010999A (es) Combinación de dosis fija en la forma de una tableta de dos capas o de una sola capa de alisquireno y amlodipina

Legal Events

Date Code Title Description
FC Application refused